A Reminder of Methylene Blue’s Effectiveness in Treating Vasoplegic Syndrome after On-Pump Cardiac Surgery
The use of methylene blue should be considered in patients who develop hypotension refractory to standard treatment after cardiac surgery.
World's Largest Resource for Cardiovascular Perfusion
The use of methylene blue should be considered in patients who develop hypotension refractory to standard treatment after cardiac surgery.
The aim of this study was to compare SkACT with an established kaolin-based ACT from Hemochron (HkACT) and anti-Xa activity in patients undergoing cardiopulmonary bypass (CPB).
Mannitol treatment of postoperative AKI induces a renal vasodilation and redistributes systemic blood flow to the kidneys.